Correlation Between Allgens Medical and Nanhua Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Allgens Medical and Nanhua Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Allgens Medical and Nanhua Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Allgens Medical Technology and Nanhua Bio Medicine, you can compare the effects of market volatilities on Allgens Medical and Nanhua Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Allgens Medical with a short position of Nanhua Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Allgens Medical and Nanhua Bio.

Diversification Opportunities for Allgens Medical and Nanhua Bio

-0.27
  Correlation Coefficient

Very good diversification

The 3 months correlation between Allgens and Nanhua is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Allgens Medical Technology and Nanhua Bio Medicine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nanhua Bio Medicine and Allgens Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Allgens Medical Technology are associated (or correlated) with Nanhua Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nanhua Bio Medicine has no effect on the direction of Allgens Medical i.e., Allgens Medical and Nanhua Bio go up and down completely randomly.

Pair Corralation between Allgens Medical and Nanhua Bio

Assuming the 90 days trading horizon Allgens Medical Technology is expected to under-perform the Nanhua Bio. But the stock apears to be less risky and, when comparing its historical volatility, Allgens Medical Technology is 1.56 times less risky than Nanhua Bio. The stock trades about -0.14 of its potential returns per unit of risk. The Nanhua Bio Medicine is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  876.00  in Nanhua Bio Medicine on December 30, 2024 and sell it today you would earn a total of  93.00  from holding Nanhua Bio Medicine or generate 10.62% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Allgens Medical Technology  vs.  Nanhua Bio Medicine

 Performance 
       Timeline  
Allgens Medical Tech 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Allgens Medical Technology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Nanhua Bio Medicine 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Nanhua Bio Medicine are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Nanhua Bio sustained solid returns over the last few months and may actually be approaching a breakup point.

Allgens Medical and Nanhua Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Allgens Medical and Nanhua Bio

The main advantage of trading using opposite Allgens Medical and Nanhua Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Allgens Medical position performs unexpectedly, Nanhua Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nanhua Bio will offset losses from the drop in Nanhua Bio's long position.
The idea behind Allgens Medical Technology and Nanhua Bio Medicine pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges